- English (USA)
- English (UK)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Standard Chemical & Pharmaceutical Co Ltd (1720)
The SCPC share price today is 60.70, view TW 1720 stock exchange data. Track the latest SCPC share price with real-time updates on 1720 stock performance including market cap, day range, 52-week range and dividend yield. Access 1720 charts, earnings dates and analyst estimates to support your investment decisions.
Taiwan
Currency in TWD
60.70
-0.30(-0.49%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
60.50
61.40
52 wk Range
53.50
66.60
Earnings results expected in 6 days
1/3
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
60.5061.40
52 wk Range
53.5066.60
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(4.66%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(4.66%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
1720 Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Price Target
73.00
Upside
+20.26%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Valuation implies a strong free cash flow yield
Analyst Ratings
1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 73.00
(+20.26% Upside)
Earnings
Latest Release
25-02-2026
EPS / Forecast
1.27 / 1.37
Revenue / Forecast
1.79B / 1.85B
Compare 1720 to Peers and Sector
Metrics to compare | 1720 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship1720PeersSector | |
|---|---|---|---|---|
P/E Ratio | 11.7x | 21.7x | −0.5x | |
PEG Ratio | 2.21 | −1.12 | 0.00 | |
Price/Book | 1.8x | 1.7x | 2.6x | |
Price / LTM Sales | 1.5x | 1.4x | 3.2x | |
Upside (Analyst Target) | - | 43.3% | 47.8% | |
Fair Value Upside | Unlock | 23.1% | 5.9% | Unlock |
Standard Chemical & Pharmaceutical Co., Ltd., together with its subsidiaries, manufactures and sells pharmaceutical products in Taiwan and internationally. The company offers Chinese and western medicines, cosmetics, beverages, general instruments, and medical devices. It also provides western pharmaceuticals for cardiovascular, metabolic, genitourinary and sex steroids, respiratory, musculoskeletal, digestive, nervous, and circulatory systems; anti-infectives and topical medications; and cancer and cancer antiemetic. In addition, the company offers health food products. Further, it is involved in the manufacture and sale of active pharmaceutical ingredients, as well as veterinary drugs; and sales of medical devices and infant milk powder. It also exports its products. The company was incorporated in 1967 and is headquartered in Tainan City, Taiwan.
Ownership
Ownership Overview
Top Holders
FAQ
What Is the SCPC (1720) Share Price Today?
The SCPC share price today is 60.70.
What is the current SCPC (1720) share price and day range?
As of 06-05-2026, the SCPC share price is 60.70, with a previous close of 60.10. The share price has ranged from 60.50 to 61.40 today, while the 52-week range spans from 53.50 to 66.60.
What Is the SCPC Market Cap?
As of today, SCPC market cap is 10.85B.
Does SCPC Pay Dividends? What's The Current Dividend Yield?
The SCPC dividend yield is 4.66%.
What Is the SCPC (1720) Share Price Target?
The average 12-month share price target for SCPC is 73.00, with a high estimate of 73 and a low estimate of 73. 1 analysts recommend buying, while 0 suggest selling, with an overall rating of Buy and +20.26% Upside potential.
What Is SCPC's Earnings Per Share (TTM)?
The SCPC EPS (TTM) is 5.18.
When Is the Next SCPC Earnings Date?
SCPC will release its next earnings report on 12-05-2026.
From a Technical Analysis Perspective, Is 1720 a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
What Stock Exchange Does SCPC Trade On?
SCPC is listed and trades on the Taiwan Stock Exchange.
What Is the Stock Symbol for SCPC?
The stock symbol for SCPC is "1720."
How Many Times Has SCPC Stock Split?
SCPC has split 9 times.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.